EFFECT OF DIFFERENT ANTICOAGULANTS IN DETERMINING METFORMIN HYDROCHLORIDE LEVELS IN HUMAN PLASMA USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Authors

  • Yahdiana Harahap
  • Lista Roro Marsudi
  • Sunarsih .

DOI:

https://doi.org/10.22159/ijap.2018.v10s1.31

Keywords:

Anticoagulant, Citrate, Ethylenediaminetetraacetic acid, Heparin, Human plasma, Validation

Abstract

Objective: This study aimed to develop and validate an analytical method and to determine the effect of different anticoagulants for analyzing
metformin HCl level in human plasma.
Methods: Analysis was performed with high-performance liquid chromatography method using a photodiode array detector set at 234 nm, a C18
SunFire™ column (5 μm, 250 mm×4.6 mm), a temperature of 40°C, a mobile phase comprising 10 mM sodium dodecyl sulfate and 10 mM phosphate
buffer in water-acetonitrile (60:40 v/v) at pH 7.0, with a flow rate of 1.0 mL/min, and atorvastatin calcium as the internal standard. Plasma
extraction was performed through protein precipitation using human plasma (300 μL) and acetonitrile (600 μL; 1:2 v/v). The method was linear at a
concentration range of 20.0–5000.0 ng/mL, with r>0.9998.
Results: The stability and recovery of metformin HCl in human plasma were not different between citrate with ethylenediaminetetraacetic acid
(EDTA) and heparin with EDTA as anticoagulants. However, a significant difference in the peak area response ratio (p<0.05) was observed between
the three anticoagulants.
Conclusion: The validation results for the three types of plasma anticoagulants met validation requirements based on the European Medicines
Agency bioanalytical guidelines of 2011 for accuracy and precision, selectivity, calibration curve linearity, dilution integrity, carry-over, and stability.

Downloads

Download data is not yet available.

References

Dipiro J, Cecily V, Barbara GW, Terry LS. Pharmacotherapy:

A Pathophysiologic Approach. 9th ed. United States: The McGraw-Hill

Companies, Inc; 2015.

Goodman L, Gilman A, Brunton L, Lazo J, Parker K. Goodman and

Gilman’s the Pharmacological Basis of Therapeutics. 1st ed. New York:

McGraw-Hill; 2006.

Food and Drug Administration. Metformin Hydrochloride Tablets. United

States of America: Department of Health and Human Services; 2002.

Heinig K, Bucheli F. Fast liquid chromatographic-tandem mass

spectrometric (LC-MS-MS) determination of metformin in plasma

samples. J Pharm Biomed Anal 2004;34:1005-11.

Zarghi A, Foroutan S, Shafaati A, Khoddam A. Rapid determination

of metformin in human plasma using ion-pair HPLC. J Pharm Biomed

Anal 2003;31:197-200.

Shargel L, Wu-Pong S, Yu ABC. Applied Biopharmaceutics and

Pharmacokinetics. 5th ed. United States of America: Appeton and

Lange; 2004.

Harahap Y. The Role of Bioanalysis in Drug Quality Assurance and

Improving Quality of Patient Life. Jakarta: UI-Press; 2010.

Bowen RA, Hortin GL, Csako G, Otañez OH, Remaley AT. Impact of

blood collection devices on clinical chemistry assays. Clin Biochem

;43:4-25.

Gonzalez-Covarrubias V, Dane A, Hankemeier T, Vreeken RJ. The

influence of citrate, EDTA, and heparin anticoagulants to human

plasma LC-MS lipidomic profiling. Metabolomics 2012;9:337-48.

Ludong MM. Blood Transfusion. Jakarta: Faculty of Medicine,

Universitas Tarumanegara; 2012. p. 1-11.

Barri T, Dragsted LO. UPLC-ESI-QTOF/MS and multivariate

data analysis for blood plasma and serum metabolomics: Effect

of experimental artefacts and anticoagulant. Anal Chim Acta

;768:118-28.

European Medicines Agency. Guideline on Bioanalytical Method

Validation. Vol. 44. London: An Agency of the European Union; 2011.

AbuRuz S, Millership J, McElnay J. Determination of metformin in

plasma using a new ion pair solid phase extraction technique and ion

pair liquid chromatography. J Chromatogr B Analyt Technol Biomed

Life Sci 2003;798:203-9.

Haque A, Priya S, Mohanty D, Bakshi V, Boggula N. Analytical method

development and validation of amlodipine in human plasma using

liquid chromatography-mass spectrometry/mass spectrometry. Asian J

Pharm Clin Res 2017;11:393-7.

Evans G. A Handbook of Bioanalysis and Drug Metabolism. United

States of America: CRC Press; 2004.

Pawar AK. Development and validation of UV spectrophotometric

and reversed phase-high performance liquid chromatography-PDA

methods for the estimation of alogliptin benzoate. Asian J Pharm Clin

Res 2017;9:282-7.

Porwal P, Talele G. Development of validated HPLC-UV method for

simultaneous determination of metformin, amlodipine, glibenclamide

and atorvastatin in human plasma and application to protein binding

studies. Bull Fac Pharm 2016;55:129-139.

Porta V, Schramm S, Kano E, Koono E, Armando Y, Fukuda K, et al.

HPLC-UV determination of metformin in human plasma for application

in pharmacokinetics and bioequivalence studies. J Pharm Biomed Anal

;46:143-7.

Chhetri H, Thapa P, Van SA. Simple HPLC-UV method for the

quantification of metformin in human plasma with one step protein

precipitation. Saudi Pharm J 2013;22:483-7.

Alakhali KM. Validation method for measuring simvastatin in human

plasma by HPLC-UV and its application ii study simvastatin stability in

plasma and working solution. Asian J Pharm Clin Res 2017;7:131-3.

Published

20-12-2018

How to Cite

Harahap, Y., Marsudi, L. R., & ., S. (2018). EFFECT OF DIFFERENT ANTICOAGULANTS IN DETERMINING METFORMIN HYDROCHLORIDE LEVELS IN HUMAN PLASMA USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. International Journal of Applied Pharmaceutics, 10(1), 148–151. https://doi.org/10.22159/ijap.2018.v10s1.31

Issue

Section

Original Article(s)

Most read articles by the same author(s)

1 2 3 > >>